Dr. Erin Phillips, MD

NPI: 1114977949
Total Payments
$646.12
2024 Payments
$219.87
Companies
15
Transactions
26
Medicare Patients
2,590
Medicare Billing
$286,943

Payment Breakdown by Category

Food & Beverage$632.95 (98.0%)
Education$13.17 (2.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $632.95 25 98.0%
Education $13.17 1 2.0%

Top Paying Companies

Company Total Records Latest Year
UCB, Inc. $173.43 2 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $116.98 1 $0 (2024)
Endo Pharmaceuticals Inc. $60.04 4 $0 (2020)
Neurocrine Biosciences, Inc. $55.88 3 $0 (2019)
Merz North America, Inc. $44.61 3 $0 (2018)
Amgen Inc. $38.07 2 $0 (2021)
EMD Serono, Inc. $32.75 2 $0 (2019)
AbbVie, Inc. $23.63 2 $0 (2018)
Valeant Pharmaceuticals North America LLC $18.53 1 $0 (2017)
Alexion Pharmaceuticals, Inc. $16.98 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $219.87 3 Takeda Pharmaceuticals U.S.A., Inc. ($116.98)
2023 $87.52 1 UCB, Inc. ($87.52)
2021 $16.50 1 Amgen Inc. ($16.50)
2020 $33.00 2 Endo Pharmaceuticals Inc. ($33.00)
2019 $112.38 7 Neurocrine Biosciences, Inc. ($40.70)
2018 $121.98 8 Merz North America, Inc. ($33.82)
2017 $54.87 4 Valeant Pharmaceuticals North America LLC ($18.53)

All Payment Transactions

26 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
09/26/2024 Takeda Pharmaceuticals U.S.A., Inc. HYQVIA (Biological) Food and Beverage In-kind items and services $116.98 General
Category: IMMUNOLOGY
03/20/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $16.98 General
Category: Rare Disease
03/04/2024 UCB, Inc. Zilbrysq (Drug) Food and Beverage In-kind items and services $85.91 General
Category: Neurology
12/05/2023 UCB, Inc. Food and Beverage In-kind items and services $87.52 General
05/18/2021 Amgen Inc. Aimovig (Biological) Food and Beverage In-kind items and services $16.50 General
Category: Neuroscience
02/20/2020 Endo Pharmaceuticals Inc. XIAFLEX (Biological), EDEX, AVEED Food and Beverage In-kind items and services $17.31 General
Category: UROLOGY
01/16/2020 Endo Pharmaceuticals Inc. XIAFLEX (Biological), EDEX, AVEED Food and Beverage In-kind items and services $15.69 General
Category: UROLOGY
11/05/2019 Endo Pharmaceuticals Inc. XIAFLEX (Biological), AVEED, EDEX Food and Beverage In-kind items and services $13.84 General
Category: UROLOGY
10/08/2019 Endo Pharmaceuticals Inc. XIAFLEX (Biological), AVEED, EDEX Food and Beverage In-kind items and services $13.20 General
Category: UROLOGY
10/03/2019 EMD Serono, Inc. Mavenclad (Biological) Education In-kind items and services $13.17 General
Category: Neurology
08/29/2019 Lilly USA, LLC EMGALITY (Drug) Food and Beverage In-kind items and services $11.89 General
Category: Neuroscience
08/15/2019 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $19.57 General
Category: NEUROLOGY
06/20/2019 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $21.13 General
Category: NEUROLOGY
05/09/2019 EMD Serono, Inc. Mavenclad (Biological) Food and Beverage In-kind items and services $19.58 General
Category: Neurology
11/08/2018 AbbVie, Inc. Duopa (Drug) Food and Beverage In-kind items and services $11.88 General
Category: Neuroscience
08/30/2018 Adamas Pharmaceuticals, Inc. GOCOVRI (Drug) Food and Beverage In-kind items and services $13.66 General
Category: PD
08/09/2018 Merz North America, Inc. XEOMIN (Biological) Food and Beverage Cash or cash equivalent $16.58 General
Category: MUSCULOSKELETAL
08/06/2018 AbbVie, Inc. Duopa (Drug) Food and Beverage In-kind items and services $11.75 General
Category: Neuroscience
06/18/2018 Amgen Inc. Aimovig (Biological) Food and Beverage In-kind items and services $21.57 General
Category: Neuroscience
03/21/2018 Merz North America, Inc. XEOMIN (Biological) Food and Beverage Cash or cash equivalent $17.24 General
Category: DERMATOLOGY
02/07/2018 BOSTON SCIENTIFIC CORPORATION GENERAL DBS (Device) Food and Beverage In-kind items and services $14.12 General
Category: DBS
01/24/2018 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $15.18 General
Category: NEUROLOGY
12/14/2017 Impax Laboratories, Inc. RYTARY (Drug) Food and Beverage In-kind items and services $10.83 General
Category: NEUROLOGY
10/05/2017 Avanir Pharmaceuticals, Inc. NUEDEXTA (Drug) Food and Beverage In-kind items and services $14.72 General
Category: pseudobulbar affect (PBA)
02/08/2017 MERZ NORTH AMERICA, INC. Xeomin (Biological) Food and Beverage Cash or cash equivalent $10.79 General
Category: Musculoskeletal

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 16 595 900 $300,284 $64,540
2022 16 629 994 $315,373 $70,813
2021 16 620 991 $307,376 $69,980
2020 18 746 1,269 $356,399 $81,609
Total Patients
2,590
Total Services
4,154
Medicare Billing
$286,943
Procedure Codes
69

All Medicare Procedures & Services

69 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99291 Critical care, first 30-74 minutes Facility 2023 61 75 $46,800 $11,879 25.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 79 113 $45,878 $11,713 25.5%
G0453 Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) Facility 2023 38 264 $19,008 $6,571 34.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 61 81 $23,409 $5,707 24.4%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 34 34 $14,994 $4,349 29.0%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 25 25 $12,400 $3,437 27.7%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 35 35 $13,125 $3,332 25.4%
95913 Nerve conduction, 13 or more studies Facility 2023 22 22 $14,608 $3,167 21.7%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 31 32 $7,296 $2,984 40.9%
95911 Nerve conduction, 9-10 studies Facility 2023 27 27 $13,284 $2,585 19.5%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Facility 2023 63 73 $16,644 $2,472 14.9%
95861 Needle measurement of electrical activity in arm or leg muscles, 2 extremities Facility 2023 37 37 $21,053 $2,329 11.1%
95938 Placement of skin electrodes and measurement of stimulated sites on arms and legs Facility 2023 37 37 $30,340 $1,297 4.3%
95910 Nerve conduction, 7-8 studies Facility 2023 14 14 $5,712 $1,142 20.0%
95909 Nerve conduction, 5-6 studies Facility 2023 20 20 $6,240 $1,094 17.5%
95816 Measurement of brain wave activity (eeg), awake and drowsy Facility 2023 11 11 $9,493 $482.57 5.1%
99291 Critical care, first 30-74 minutes Facility 2022 74 96 $59,224 $15,758 26.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 68 87 $33,162 $9,689 29.2%
G0453 Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) Facility 2022 40 322 $23,344 $8,121 34.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 63 78 $20,634 $5,750 27.9%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 26 26 $11,490 $3,786 33.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 32 36 $11,376 $3,462 30.4%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 28 28 $10,230 $2,874 28.1%
95720 Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional Facility 2022 11 16 $8,500 $2,551 30.0%
95861 Needle measurement of electrical activity in arm or leg muscles, 2 extremities Facility 2022 38 38 $21,755 $2,429 11.2%

About Dr. Erin Phillips, MD

Dr. Erin Phillips, MD is a Internal Medicine healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114977949.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erin Phillips, MD has received a total of $646.12 in payments from pharmaceutical and medical device companies, with $219.87 received in 2024. These payments were reported across 26 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($632.95).

As a Medicare-enrolled provider, Phillips has provided services to 2,590 Medicare beneficiaries, totaling 4,154 services with total Medicare billing of $286,943. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Neurology
  • Location Tyler, TX
  • Active Since 05/11/2006
  • Last Updated 06/17/2015
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1114977949

Products in Payments

  • HYQVIA (Biological) $116.98
  • Zilbrysq (Drug) $85.91
  • XIAFLEX (Biological) $60.04
  • INGREZZA (Drug) $55.88
  • Aimovig (Biological) $38.07
  • XEOMIN (Biological) $33.82
  • Mavenclad (Biological) $32.75
  • Duopa (Drug) $23.63
  • ULTRA (Device) $18.53
  • ULTOMIRIS (Biological) $16.98
  • NUEDEXTA (Drug) $14.72
  • GENERAL DBS (Device) $14.12
  • GOCOVRI (Drug) $13.66
  • EMGALITY (Drug) $11.89
  • RYTARY (Drug) $10.83
  • Xeomin (Biological) $10.79

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Tyler